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Serum samples were obtained from 24 horses in the
State of Coahuila, Mexico, in December 2002. Antibodies to
West Nile virus were detected by epitope-blocking enzyme-
linked immunosorbent assay and confirmed by plaque
reduction neutralization test in 15 (62.5%) horses. We
report the first West Nile virus activity in northern Mexico.
W
est Nile virus (WNV; family Flaviviridae, genus
Flavivirus) is a member of the Japanese encephalitis
virus complex, which also includes Japanese encephalitis
virus, Saint Louis encephalitis virus (SLEV), and Murray
Valley encephalitis virus (1). These viruses are maintained
in cycles between mosquitoes and birds (2). The principal
vectors for WNV are Culex species mosquitoes, and many
species of wild birds act as vertebrate hosts (3). Humans,
horses, and other mammals usually serve as dead-end
hosts. In humans and equines, WNV infection is usually
asymptomatic or characterized by a mild febrile illness,
although fatal meningoencephalitis or encephalitis may
occur (3–5). WNV has a broad geographic distribution,
recently including North America (4,5). The initial out-
break of WNV in North America was recognized in New
York City in August 1999. Since then, WNV’s geographic
range has increased. WNV activity has now been reported
in 44 states in the United States, the District of Columbia,
and 5 of the 10 Canadian provinces (6,7).
In anticipation of the possible emergence of WNV into
Mexico, we conducted equine infection surveillance in the
northeastern states of Mexico. Coahuila State is bordered
on the north by Texas. WNV activity has been detected in
204 (80%) of 254 Texas counties, including most counties
that border Coahuila State (8). Therefore, Coahuila State
was considered to be a likely point of incursion of WNV
into Mexico from the United States.
Case Study
We present data from a small equine serosurvey con-
ducted in Coahuila State in December 2002. Amore exten-
sive equine serosurvey is currently under way and will be
described in detail elsewhere (B.J. Beaty, unpub. data). In
the present study, blood samples were taken from 24
domestic horses at study sites located in Ciudad Acuña,
Jiménez, and Saltillo (Figure). The Ciudad Acuña and
Jiménez sites are approximately 40 km apart, and both are
<15 km from the Texas border. Saltillo is located in the
southeast region of Coahuila State and is approximately
220 km from Texas. All study sites are privately owned
ranches.
The climatic conditions of the three study sites are sim-
ilar and can be described as hot, dry, and arid. The average
annual temperature ranges from 18°C to 22°C. The aver-
age rainfall is from 100 to 300 mm per year. The sites in
Ciudad Acuña and Jiménez are approximately 300 m
above sea level. The Saltillo site is situated at an elevation
of approximately 1500 m.
Ahorse from the Ciudad Acuña ranch died October 17,
3 days after being observed with neurologic signs. The
case was not reported immediately, and we were unable to
obtain a tissue specimen postmortem. On December 19,
with the assistance of a local veterinary practitioner, we
sampled 14 horses at this site, 5 of which had developed
neurologic disease in mid- to late October. Clinical symp-
toms included ataxia, weakness of limbs, trembling, and
anxiety. All five horses survived. The horses with clinical
signs were from 1 to 5 years of age; three were male, and
two were female. Ages and sexes of horses without clini-
cal symptoms were not documented. The veterinarian
reported a great abundance of mosquitoes in the area.
Another six horses were sampled in Jiménez and four in
Saltillo, none of which had signs of illness. According to
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Figure. Geographic location of West Nile virus study sites in
Coahuila State, Mexico.the owners, none of the horses had ever been outside the
State of Coahuila, and none of the horses had been vacci-
nated against WNV. 
All serum samples were tested for antibodies to WNV
by epitope-blocking enzyme-linked immunosorbent assay
(ELISA). Blocking ELISAs were performed by using the
WNV-specific monoclonal antibody (MAb) 3.1112G, as
previously described (9). The ability of the Mexican horse
serum samples to block the binding of the MAb to WNV
antigen was compared to the blocking ability of horse
serum without antibody to WNV (Vector Laboratories,
Burlingame, CA). Data were expressed as relative percent-
ages by using the formula of Hall et al., (10). Previously,
we considered an inhibition value >30% to indicate the
presence of viral antibodies (9). Recently, we have shown
that ELISAs performed with MAb 3.1112G detect WNV
antibodies in various vertebrate species, including horses
(9,11).
Fourteen serum samples were positive in blocking
ELISA that utilized MAb 3.1112G (Table). Serum from
another horse (H-16) inhibited the binding of MAb by
25%, which is close to the diagnostic criterion. Previously,
we observed that the nonspecific inhibition values for
serum samples from noninfected control birds ranged from
0% to 24.3% (9). Therefore, if we used a less stringent
threshold value of >25%, this serum could be considered
positive for WNV antibodies.
To validate the above assays, we tested serum samples
for neutralizing antibodies to WNV and SLEV by plaque
reduction neutralization assay (PRNT). Testing for neutral-
izing antibody to SLEV was important because this virus
is enzootic in the Americas and antibodies to WNV and
SLEV often cross-react. Furthermore, horses are suscepti-
ble to SLEV infection, although clinical manifestations
have not been reported (12). Viral isolates of WNV (strain
NY99-35261-11) and SLEV (strain TBH-28) were
obtained from the World Health Organization Center for
Arbovirus Reference and Research, maintained at the
Centers for Disease Control and Prevention, Division of
Vector-Borne Infectious Diseases, Fort Collins, CO.
PRNTs were performed by using Vero cells. Serum sam-
ples were tested by using a starting dilution of 1:20. Titers
were expressed as the reciprocal of serum dilutions reduc-
ing the number of plaques that were >90% (PRNT90). 
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Horse  Study site  Clinical illness 
% inhibition by 
ELISA
b  WNV  SLEV  PRNT diagnosis 
H-1  Ciudad Acuña  No  90  >320 
—d  WNV 
H-2  Ciudad Acuña  No  5  —  —  Negative 
H-3  Ciudad Acuña  No  0  —  —  Negative 
H-4  Ciudad Acuña  No  0  —  —  Negative 
H-5  Ciudad Acuña  No  90  >320  40  WNV 
H-6  Ciudad Acuña  No  93  >320  —  WNV 
H-7  Ciudad Acuña  No  93  >320  —  WNV 
H-8  Ciudad Acuña  Yes  93  >320  —  WNV 
H-9  Ciudad Acuña  Yes  86  >320  —  WNV 
H-10  Ciudad Acuña  Yes  90  >320  20  WNV 
H-11  Ciudad Acuña  No  89  >320  —  WNV 
H-12  Ciudad Acuña  No  92  >320  20  WNV 
H-13  Ciudad Acuña  Yes  91  >320  —  WNV 
H-14  Ciudad Acuña  Yes  78  >320  20  WNV 
H-15  Jiménez  No  82  >320  —  WNV 
H-16  Jiménez  No  25  40  —  WNV 
H-17  Jiménez  No  7  —  —  Negative 
H-18  Jiménez  No  93  >320  20  WNV 
H-19  Jiménez  No  0  20  20  Flavivirus 
H-20  Jiménez  No  47  40  —  WNV 
H-21  Saltillo  No  9  —  —  Negative 
H-22  Saltillo  No  15  —  —  Negative 
H-23  Saltillo  No  12  —  —  Negative 
H-24  Saltillo  No  11  —  —  Negative 
aELISA, enzyme-linked immunosorbent assay; PRNT, plaque reduction neutralization test; WNV, West Nile virus; SLEV, Saint Louis encephalitis virus. 
bInhibition values >30% are considered significant. 
cNeutralizing antibodies to WNV in selected horse serum samples were confirmed at Centers for Disease Control and Prevention-Division of Viral and Bacterial 
Infectious Diseases by PRNT. 
d—, <20. Conclusions 
Overall, PRNT and ELISA data were in concordance.
Fifteen (62.5%) horses were considered to be seropositive
for WNV by PRNT because the antibody titers for WNV
were greater than or equal to fourfold higher that the cor-
responding SLEV titer (Table). These 15 were the same
serum samples that had inhibition values of >25% by
ELISA. Of these, 11 horses were from Ciudad Acuña, and
4 were from Jiménez. Evidence for WNV infections was
detected in 5 (100%) of 5 horses with clinical symptoms,
and 10 (52.6%) of 19 horses without clinical symptoms.
Therefore, the rate of asymptomatic seropositivity was
high, with 10 (66.7%) of 15 WNV-infected horses showing
no signs of illness. Similarly, 21 (58.3%) of 36 WNV-
infected horses sampled during a serosurvey in New York
in 1999 showed no clinical signs (13). However, the sam-
ple population (n=24) in the present serosurvey was
notably small, and data from our large equine serosurvey
will provide a more reliable estimate of the asymptomatic
seropositivity rate.
We were unable to detect RNA in any horse serum by
reverse-transcription polymerase chain reaction with
WNV-specific primers (14). We plan to isolate and ampli-
fy WNV RNA sequences from tissue specimens obtained
from seropositive horses, as well as from birds, in future
studies.
We are currently conducting avian infection surveil-
lance in the State of Coahuila and the neighboring states of
Tamaulipas and Nuevo Leon. Preliminary evidence sug-
gests that several birds from a region in Nuevo Leon State
have antibodies to WNV(I. Fernandez-Salas, unpub. data).
The birds were trapped in February 2003, 2 months after
we obtained samples from the horses in Coahuila State.
However, equine cases often precede the detection of
seropositive birds. For example, an equine case was the
first indication of WNV activity in 29% (660/2,289) of the
United States counties to report virus activity in 2002 (6).
In summary, we have obtained serologic evidence for
antibodies to WNV in horses in the State of Coahuila,
Mexico. In the accompanying manuscript, we report the
detection of antibodies to WNV in horses in the State of
Yucatan (15). These two reports provide the first published
evidence of WNV activity in horses in Mexico. Antibodies
to WNV, or a closely related virus, were detected in a sin-
gle bovine during a serosurvey in Chiapas, Mexico, in
mid-2001 (16). WNV will probably become endemic in
Mexico, which is a major concern to public health author-
ities in the Americas. Our findings demonstrate the impor-
tance for continued WNV surveillance in Mexico.
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